The advent of modern pharmaceuticals has markedly improved the public health in developed countries, yet in the developing world, disease is pandemic. In this article, the author outlines the difficulties inherent in regulating the export and production of drugs for less developed countries. The author first traces the history of anglo-american drug legislation as a prelude to discussion of the characteristics of the pharmaceutical industry. Next, the author sets forth the major problems as seen by the developing world regarding pharmaceutical imports. Lastly, the author offers proposals for ameliorative regulations in this area.
Nancy E. Pirt,
Regulation of the Export of Pharmaceuticals to Developing Countries,
Duq. L. Rev.
Available at: https://dsc.duq.edu/dlr/vol25/iss2/4